{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:57:13Z","timestamp":1785787033372,"version":"3.56.0"},"reference-count":131,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1097\/01.inf.0000108192.94692.d2","type":"journal-article","created":{"date-parts":[[2004,1,23]],"date-time":"2004-01-23T04:04:23Z","timestamp":1074830663000},"page":"S46-S57","source":"Crossref","is-referenced-by-count":36,"title":["Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection"],"prefix":"10.1097","volume":"23","author":[{"given":"TERESA R.","family":"JOHNSON","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BARNEY S.","family":"GRAHAM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-8-20210202","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1073\/pnas.84.16.5625","article-title":"The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins","volume":"84","author":"Johnson","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"R3-8-20210202","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1099\/0022-1317-72-2-349","article-title":"Respiratory syncytial virus heterogeneity during an epidemic: analysis by limited nucleotide sequencing (SHgene) and restriction mapping (Ngene)","volume":"72","author":"Cane","year":"1991","journal-title":"J Gen Virol"},{"key":"R4-8-20210202","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/infdis\/163.4.858","article-title":"Antigenic and genomic diversity within group A respiratory syncytial virus","volume":"163","author":"Storch","year":"1991","journal-title":"J Infect Dis"},{"key":"R5-8-20210202","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/infdis\/163.4.687","article-title":"Multicenter study of strains of respiratory syncytial virus","volume":"163","author":"Anderson","year":"1991","journal-title":"J Infect Dis"},{"key":"R6-8-20210202","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/BF02718156","article-title":"Respiratory syncytial virus: virology, diagnosis, and vaccination","volume":"168","author":"Toms","year":"1990","journal-title":"Lung"},{"key":"R7-8-20210202","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1086\/513976","article-title":"Severity of respiratory syncytial virus infection is related to virus strain","volume":"175","author":"Walsh","year":"1997","journal-title":"J Infect Dis"},{"key":"R8-8-20210202","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/jmv.10225","article-title":"Molecular epidemiological analysis of community circulating respiratory syncytial virus in rural South Africa: comparison of viruses and genotypes responsible for different disease manifestations","volume":"68","author":"Venter","year":"2002","journal-title":"J Med Virol"},{"key":"R9-8-20210202","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1128\/JCM.38.10.3849-3852.2000","article-title":"G protein variation in respiratory syncytial virus group A does not correlate with clinical severity","volume":"38","author":"Brandenburg","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R10-8-20210202","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1099\/0022-1317-68-6-1705","article-title":"Appearance of a soluble form of the G protein of respiratory syncytial virus in fluids of infected cells","volume":"68","author":"Hendricks","year":"1987","journal-title":"J Gen Virol"},{"key":"R11-8-20210202","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1128\/JVI.62.7.2228-2233.1988","article-title":"Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus","volume":"62","author":"Hendricks","year":"1988","journal-title":"J Virol"},{"key":"R12-8-20210202","doi-asserted-by":"crossref","first-page":"13961","DOI":"10.1073\/pnas.94.25.13961","article-title":"Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replicationin vitro: clinical evaluation and molecular characterization of a cold-passaged attenuated RSV subgroup B mutant","volume":"94","author":"Karron","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"R13-8-20210202","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/infdis\/173.4.829","article-title":"Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates","volume":"173","author":"Crowe","year":"1996","journal-title":"J Infect Dis"},{"key":"R14-8-20210202","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/viro.2000.0293","article-title":"Iuronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection","volume":"271","author":"Hallak","year":"2000","journal-title":"Virology"},{"key":"R15-8-20210202","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1128\/JVI.74.14.6442-6447.2000","article-title":"The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate","volume":"74","author":"Feldman","year":"2000","journal-title":"J Virol"},{"key":"R16-8-20210202","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/viro.2001.1340","article-title":"Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus","volume":"294","author":"Techaarpornkul","year":"2002","journal-title":"Virology"},{"key":"R17-8-20210202","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1099\/0022-1317-81-11-2715","article-title":"Binding of human respiratory syncytial virus to cells: implication of sulfated cell surface proteoglycans","volume":"81","author":"Martinez","year":"2000","journal-title":"J Gen Virol"},{"key":"R18-8-20210202","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/90675","article-title":"CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein","volume":"2","author":"Tripp","year":"2001","journal-title":"Nat Immunol"},{"key":"R19-8-20210202","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1046\/j.1462-5822.2003.00313.x","article-title":"Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response","volume":"5","author":"Harris","year":"2003","journal-title":"Cell Microbiol"},{"key":"R20-8-20210202","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1128\/JVI.68.7.4538-4546.1994","article-title":"The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons","volume":"68","author":"Roberts","year":"1994","journal-title":"J Virol"},{"key":"R21-8-20210202","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jlb.59.3.403","article-title":"Respiratory syncytial virus G-protein modulates cytokine release from peripheral blood mononuclear cells","volume":"59","author":"Konig","year":"1996","journal-title":"J Leuk Biol"},{"key":"R22-8-20210202","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/(SICI)1096-9071(199607)49:3<161::AID-JMV2>3.0.CO;2-2","article-title":"Different patterns of cytokine induction in cultures of respiratory syncytial (RS) virus-specific human Thcell lines following stimulation with RS virus and RS virus proteins","volume":"49","author":"Jackson","year":"1996","journal-title":"J Med Virol"},{"key":"R23-8-20210202","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1203\/00006450-197601000-00015","article-title":"Cell-mediated immunity to respiratory syncytial virus induced by inactivated vaccine or by infection","volume":"10","author":"Kim","year":"1976","journal-title":"Pediatr Res"},{"key":"R24-8-20210202","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1128\/JVI.65.7.3789-3796.1991","article-title":"Immunodominant T-cell epitope on the F protein of respiratory syncytial virus recongized by human lymphocytes","volume":"65","author":"Levely","year":"1991","journal-title":"J Virol"},{"key":"R25-8-20210202","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1128\/JVI.64.9.4232-4241.1990","article-title":"Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins","volume":"64","author":"Nicholas","year":"1990","journal-title":"J Virol"},{"key":"R26-8-20210202","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1128\/JCM.23.3.475-480.1986","article-title":"Identification of epitopes on respiratory syncytial virus proteins by competitive binding immunoassay","volume":"23","author":"Anderson","year":"1986","journal-title":"J Clin Microbiol"},{"key":"R27-8-20210202","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.4049\/jimmunol.137.12.3973","article-title":"Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants","volume":"137","author":"Bangham","year":"1986","journal-title":"J Immunol"},{"key":"R28-8-20210202","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1099\/0022-1317-70-1-79","article-title":"Recognition of respiratory syncytial virus fusion protein by mouse cytotoxic T cell clones and a human cytotoxic T cell line","volume":"70","author":"Cannon","year":"1989","journal-title":"J Gen Virol"},{"key":"R29-8-20210202","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1099\/0022-1317-67-4-623","article-title":"Murine cytotoxic T cells specific to respiratory syncytial virus recognize different antigenic subtypes of the virus","volume":"67","author":"Bangham","year":"1986","journal-title":"J Gen Virol"},{"key":"R30-8-20210202","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1128\/JCM.24.5.894-898.1986","article-title":"Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection","volume":"24","author":"Murphy","year":"1986","journal-title":"J Clin Microbiol"},{"key":"R31-8-20210202","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1073\/pnas.83.19.7462","article-title":"Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity","volume":"83","author":"Olmsted","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"R32-8-20210202","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/163.4.693","article-title":"Immunity to and frequency of reinfection with respiratory syncytial virus","volume":"163","author":"Hall","year":"1991","journal-title":"J Infect Dis"},{"key":"R33-8-20210202","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/jmv.1890070403","article-title":"Maternal antibody and respiratory syncytial virus infection in infancy","volume":"7","author":"Oglivie","year":"1981","journal-title":"J Med Virol"},{"key":"R34-8-20210202","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(81)91389-1","article-title":"HLA-restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines","volume":"2","author":"Ennis","year":"1981","journal-title":"Lancet"},{"key":"R35-8-20210202","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0045-9380(93)90003-U","article-title":"Respiratory syncytial virus","volume":"23","author":"Ruuskanen","year":"1993","journal-title":"Curr Prob Pediatr"},{"key":"R36-8-20210202","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/infdis\/164.1.15","article-title":"Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections","volume":"164","author":"Muelenaer","year":"1991","journal-title":"J Infect Dis"},{"key":"R37-8-20210202","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0022-3476(05)81135-7","article-title":"Respiratory syncytial virus puzzle: clinical features, pathophysiology, treatment, and prevention","volume":"121","author":"La Via","year":"1992","journal-title":"J Pediatr"},{"key":"R38-8-20210202","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jama.282.15.1440","article-title":"Bronchiolitis-associated hospitalizations among US children, 1980\u20131996","volume":"282","author":"Shay","year":"1999","journal-title":"JAMA"},{"key":"R39-8-20210202","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1542\/peds.95.4.500","article-title":"Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls","volume":"95","author":"Sigurs","year":"1995","journal-title":"Pediatrics"},{"key":"R40-8-20210202","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ppul.1950150104","article-title":"The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7\u20138 years","volume":"15","author":"Welliver","year":"1993","journal-title":"Pediatr Pulmonol"},{"key":"R41-8-20210202","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ppul.10365","article-title":"Risk factors for recurrent wheezing following acute bronchiolitis: a 12-month follow-up","volume":"36","author":"Cifuentes","year":"2003","journal-title":"Pediatr Pulmonol"},{"key":"R42-8-20210202","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1183\/09031936.02.00019902","article-title":"RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life","volume":"20","author":"Schauer","year":"2002","journal-title":"Eur Respir J"},{"key":"R43-8-20210202","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1164\/ajrccm.161.5.9906076","article-title":"Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7","volume":"161","author":"Sigurs","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R44-8-20210202","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(98)10321-5","article-title":"Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years","volume":"354","author":"Stein","year":"1999","journal-title":"Lancet"},{"key":"R45-8-20210202","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/infdis\/174.3.456","article-title":"Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults","volume":"174","author":"Dowell","year":"1996","journal-title":"J Infect Dis"},{"key":"R46-8-20210202","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/infdis\/162.2.568","article-title":"Serologic evidence of respiratory syncytial virus infection in nursing home patients","volume":"162","author":"Falsey","year":"1990","journal-title":"J Infect Dis"},{"key":"R47-8-20210202","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"R48-8-20210202","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0022-3476(80)80799-2","article-title":"Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity","volume":"96","author":"Fishaut","year":"1980","journal-title":"J Pediatr"},{"key":"R49-8-20210202","first-page":"393","article-title":"Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients","volume":"16","author":"Whimbey","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"R50-8-20210202","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/clinids\/22.5.778","article-title":"Community respiratory virus infections among hospitalized adult bone marrow transplant recipients","volume":"22","author":"Whimbey","year":"1996","journal-title":"Clin Infect Dis"},{"key":"R51-8-20210202","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM198607103150201","article-title":"Respiratory syncytial viral infection in children with compromised immune function","volume":"315","author":"Hall","year":"1986","journal-title":"N Engl J Med"},{"key":"R52-8-20210202","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0091-6749(76)90011-7","article-title":"Bronchiolitis and asthma: possible common pathogenetic pathways","volume":"57","author":"McIntosh","year":"1976","journal-title":"J Allergy Clin Immunol"},{"key":"R53-8-20210202","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1186\/rr186","article-title":"Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease","volume":"3","author":"Sigurs","year":"2002","journal-title":"Respir Res"},{"key":"R54-8-20210202","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1053\/rmed.2002.1297","article-title":"The association between respiratory syncytial virus infectin and reactive airway disease","volume":"96","author":"Piedimonte","year":"2002","journal-title":"Respir Med"},{"key":"R55-8-20210202","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1097\/01.inf.0000053889.39392.a7","article-title":"Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma","volume":"22","author":"Martinez","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R56-8-20210202","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1034\/j.1398-9995.2002.02169.x","article-title":"Respiratory viruses: do they protect from or induce asthma?","volume":"57","author":"Mallia","year":"2002","journal-title":"Allergy"},{"key":"R57-8-20210202","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"key":"R58-8-20210202","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","article-title":"An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine","volume":"89","author":"Kapikian","year":"1969","journal-title":"Am J Epidemiol"},{"key":"R59-8-20210202","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.20020781","article-title":"A role for immune complexes in enhanced respiratory syncytial virus disease","volume":"196","author":"Polack","year":"2002","journal-title":"J Exp Med"},{"key":"R60-8-20210202","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/JVI.57.3.721-728.1986","article-title":"Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated virus","volume":"57","author":"Prince","year":"1986","journal-title":"J Virol"},{"key":"R61-8-20210202","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0264-410X(90)90253-I","article-title":"Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3\u20136 months after immunization","volume":"8","author":"Murphy","year":"1990","journal-title":"Vaccine"},{"key":"R62-8-20210202","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1128\/JVI.70.5.2852-2860.1996","article-title":"Respiratory syncytial virus infection in BALB\/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern","volume":"70","author":"Waris","year":"1996","journal-title":"J Virol"},{"key":"R63-8-20210202","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.4049\/jimmunol.151.4.2032","article-title":"Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus","volume":"151","author":"Graham","year":"1993","journal-title":"J Immunol"},{"key":"R64-8-20210202","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1172\/JCI117546","article-title":"Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus","volume":"94","author":"Tang","year":"1994","journal-title":"J Clin Invest"},{"key":"R65-8-20210202","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1164\/ajrccm\/152.4_Pt_2.S63","article-title":"Pathogenesis of respiratory syncytial virus vaccine-augmented pathology","volume":"152","author":"Graham","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"R66-8-20210202","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1172\/JCI119391","article-title":"T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice","volume":"99","author":"Tang","year":"1997","journal-title":"J Clin Invest"},{"key":"R67-8-20210202","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/infdis\/172.3.734","article-title":"Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity","volume":"172","author":"Tang","year":"1995","journal-title":"J Infect Dis"},{"key":"R68-8-20210202","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1128\/JVI.61.12.3855-3861.1987","article-title":"Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus","volume":"61","author":"Stott","year":"1987","journal-title":"J Virol"},{"key":"R69-8-20210202","doi-asserted-by":"crossref","first-page":"7783","DOI":"10.1128\/JVI.70.11.7783-7791.1996","article-title":"Generation of atypical pulmonary inflammatory responses in BALB\/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus","volume":"70","author":"Hancock","year":"1996","journal-title":"J Virol"},{"key":"R70-8-20210202","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/intimm\/4.4.493","article-title":"Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G","volume":"4","author":"Openshaw","year":"1992","journal-title":"Int Immunol"},{"key":"R71-8-20210202","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1128\/JVI.71.1.678-685.1997","article-title":"Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection","volume":"71","author":"Srikiatkhachorn","year":"1997","journal-title":"J Virol"},{"key":"R72-8-20210202","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1128\/JVI.72.4.2871-2880.1998","article-title":"Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge","volume":"72","author":"Johnson","year":"1998","journal-title":"J Virol"},{"key":"R73-8-20210202","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.4049\/jimmunol.161.5.2473","article-title":"Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB\/c mice sensitized to the attachment G protein","volume":"61","author":"Bembridge","year":"1998","journal-title":"J Immunol"},{"key":"R74-8-20210202","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1084\/jem.179.1.81","article-title":"Distinct types of lung disease caused by functional subsets of antiviral T cells","volume":"179","author":"Alwan","year":"1994","journal-title":"J Exp Med"},{"key":"R75-8-20210202","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.4049\/jimmunol.161.11.6215","article-title":"Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection","volume":"161","author":"Hussell","year":"1998","journal-title":"J Immunol"},{"key":"R76-8-20210202","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1128\/JVI.73.10.8485-8495.1999","article-title":"Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism","volume":"73","author":"Johnson","year":"1999","journal-title":"J Virol"},{"key":"R77-8-20210202","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1128\/JVI.73.8.6590-6597.1999","article-title":"Induction of Th-1 and Th-2 responses by respiratory syncytial virus attachment glycoprotein is epitope and major histocompatibility complex independent","volume":"73","author":"Srikiatkhachorn","year":"1999","journal-title":"J Virol"},{"key":"R78-8-20210202","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1084\/jem.188.10.1967","article-title":"Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus","volume":"188","author":"Tebbey","year":"1998","journal-title":"J Exp Med"},{"key":"R79-8-20210202","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1084\/jem.187.11.1921","article-title":"Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia","volume":"187","author":"Sparer","year":"1998","journal-title":"J Exp Med"},{"key":"R80-8-20210202","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.4049\/jimmunol.165.11.6487","article-title":"The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+T cell responses","volume":"165","author":"Varga","year":"2000","journal-title":"J Immunol"},{"key":"R81-8-20210202","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1074-7613(01)00209-6","article-title":"Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4+T cells","volume":"15","author":"Varga","year":"2001","journal-title":"Immunity"},{"key":"R82-8-20210202","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.4049\/jimmunol.170.4.2037","article-title":"IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge","volume":"170","author":"Johnson","year":"2003","journal-title":"J Immunol"},{"key":"R83-8-20210202","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4049\/jimmunol.159.1.328","article-title":"IL-12 treatment attenuates T helper cell type 2 and B cell responses but does not improve vaccine-enhanced lung illness","volume":"159","author":"Hussell","year":"1997","journal-title":"J Immunol"},{"key":"R84-8-20210202","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1099\/0022-1317-82-9-2107","article-title":"Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine","volume":"82","author":"Johnson","year":"2001","journal-title":"J Gen Virol"},{"key":"R85-8-20210202","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1084\/jem.186.3.421","article-title":"Virus-specific, CD8+T lymphocytes down regulate Th2 type cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection","volume":"186","author":"Srikiatkhachorn","year":"1997","journal-title":"J Exp Med"},{"key":"R86-8-20210202","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1002\/eji.1830271233","article-title":"CD8+T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection","volume":"27","author":"Hussell","year":"1997","journal-title":"Eur J Immunol"},{"key":"R87-8-20210202","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1099\/0022-1317-79-11-2593","article-title":"Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+T cell recruitment during respiratory syncytial virus infection","volume":"79","author":"Hussell","year":"1998","journal-title":"J Gen Virol"},{"key":"R88-8-20210202","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.4049\/jimmunol.168.6.2944","article-title":"The role of IFN in respiratory syncytial virus pathogenesis","volume":"168","author":"Durbin","year":"2002","journal-title":"J Immunol"},{"key":"R89-8-20210202","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/JVI.61.2.293-301.1987","article-title":"Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated mice","volume":"61","author":"Wertz","year":"1987","journal-title":"J Virol"},{"key":"R90-8-20210202","doi-asserted-by":"crossref","first-page":"10086","DOI":"10.1128\/JVI.73.12.10086-10094.1999","article-title":"Priming with a secreted form of the fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge","volume":"73","author":"Bembridge","year":"1999","journal-title":"J Virol"},{"key":"R91-8-20210202","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1128\/JVI.69.5.2776-2785.1995","article-title":"Preferential recognition of hepatitis B nucleocapsid antigens by Th1 or Th2 cells is epitope and major histocompatibility complex dependent","volume":"69","author":"Milich","year":"1995","journal-title":"J Virol"},{"key":"R92-8-20210202","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1172\/JCI8624","article-title":"Th2 response induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4","volume":"105","author":"Herrick","year":"2000","journal-title":"J Clin Invest"},{"key":"R93-8-20210202","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000237465","article-title":"Role of particulate antigens ofAspergillusin murine eosinophilia","volume":"112","author":"Kurup","year":"1997","journal-title":"Inter Arch Allergy Appl Immunol"},{"key":"R94-8-20210202","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/viro.2001.1138","article-title":"Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replicationin vitroandin vivo","volume":"289","author":"Teng","year":"2001","journal-title":"Virology"},{"key":"R95-8-20210202","doi-asserted-by":"crossref","first-page":"11017","DOI":"10.1128\/JVI.74.23.11017-11026.2000","article-title":"Respiratory syncytial virus can tolerate an intergenic sequence of at least 160 nucleotides with little effect on transcription or replicationin vitroandin vivo","volume":"74","author":"Bukreyev","year":"2000","journal-title":"J Virol"},{"key":"R96-8-20210202","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/jmv.2196","article-title":"Genetic susceptibility to respiratory syncytial virus infection in inbred mice","volume":"67","author":"Stark","year":"2002","journal-title":"J Med Virol"},{"key":"R97-8-20210202","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200106213442507","article-title":"Respiratory syncytial virus and parainfluenza virus","volume":"344","author":"Hall","year":"2001","journal-title":"N Engl J Med"},{"key":"R98-8-20210202","first-page":"184","article-title":"Effect of respiratory syncytial virus-antibody complexes on cytokine (IL-8, IL-6, TNF-alpha) release and respiratory burst in human granulocytes","volume":"82","author":"Arnold","year":"1994","journal-title":"Immunology"},{"key":"R99-8-20210202","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1164\/ajrccm.159.6.9805083","article-title":"Respiratory syncytial virus-induced chemokine expression in the lower airways. Eosinophil recruitment and degranulation","volume":"159","author":"Harrison","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"R100-8-20210202","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/clim.2000.4914","article-title":"Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus","volume":"97","author":"Noah","year":"2000","journal-title":"Clin Immunol"},{"key":"R101-8-20210202","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0198-8859(02)00705-X","article-title":"Cytokine gene polymorphisms moderate responses to respiratory syncytial virus in adults","volume":"64","author":"Gentile","year":"2002","journal-title":"Hum Immunol"},{"key":"R102-8-20210202","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ppul.10080","article-title":"Respiratory syncytial virus bronchiolitis: disease severity, interleukin-8, and virus genotype","volume":"33","author":"Smyth","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"R103-8-20210202","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/thorax.55.12.1023","article-title":"Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families","volume":"55","author":"Hull","year":"2002","journal-title":"Thorax"},{"key":"R104-8-20210202","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1086\/321291","article-title":"Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus","volume":"69","author":"Hull","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R105-8-20210202","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/345859","article-title":"Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms","volume":"187","author":"Hoebee","year":"2003","journal-title":"J Infect Dis"},{"key":"R106-8-20210202","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1086\/344310","article-title":"A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children","volume":"186","author":"Choi","year":"2002","journal-title":"J Infect Dis"},{"key":"R107-8-20210202","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1165\/ajrcmb.23.5.3771","article-title":"Surfactant protein-A enhances uptake of respiratory syncytial virus by monocytes and U937 macrophages","volume":"23","author":"Barr","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R108-8-20210202","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1086\/315134","article-title":"Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralies virion infectivity","volume":"180","author":"Ghildyal","year":"1999","journal-title":"J Infect Dis"},{"key":"R109-8-20210202","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3478::AID-IMMU3478>3.0.CO;2-W","article-title":"A recombinant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infectionin vitroandin vivo","volume":"29","author":"Hickling","year":"1999","journal-title":"Eur J Immunol"},{"key":"R110-8-20210202","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1172\/JCI5849","article-title":"Surfactant protein-A enhances respiratory syncytial virus clearancein vivo","volume":"103","author":"LeVine","year":"1999","journal-title":"J Clin Invest"},{"key":"R111-8-20210202","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1164\/ajrccm.159.4.9709065","article-title":"Surfactant protein levels in severe respiratory synycytial virus infection","volume":"159","author":"Kerr","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"R112-8-20210202","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/adc.75.2.133","article-title":"Surfactant abnormalities in infants with severe bronchiolitis","volume":"75","author":"Dargaville","year":"1996","journal-title":"Arch Dis Child"},{"key":"R113-8-20210202","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1086\/338473","article-title":"Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants","volume":"185","author":"L\u00f6fgren","year":"2002","journal-title":"J Infect Dis"},{"key":"R114-8-20210202","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1203\/00006450-200206000-00006","article-title":"Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection","volume":"51","author":"Lahti","year":"2002","journal-title":"Pediatr Res"},{"key":"R115-8-20210202","first-page":"L831","article-title":"Respiratory syncytial virus upregulates expression of the substance P receptor in rat lungs","volume":"277","author":"Piedimonte","year":"1999","journal-title":"Am J Physiol"},{"key":"R116-8-20210202","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/01.inf.0000053888.67311.1d","article-title":"Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection","volume":"22","author":"Piedimonte","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R117-8-20210202","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1128\/JVI.74.4.1614-1622.2000","article-title":"Respiratory syncytial virus infection and G and\/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB\/c mice","volume":"74","author":"Tripp","year":"2000","journal-title":"J Virol"},{"key":"R118-8-20210202","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/15622970309167952","article-title":"Substance P and substance P receptor antagonists in the pathogenesis and treatment of affective disorders","volume":"4","author":"Herpfer","year":"2003","journal-title":"World J Biol Psychiatry"},{"key":"R119-8-20210202","first-page":"24","article-title":"Polymorphism of angiotensin-converting enzyme gene and genetic susceptibility to asthma with familial aggregation","volume":"15","author":"Gao","year":"2000","journal-title":"Chin Med Sci J"},{"key":"R120-8-20210202","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0954-6111(98)90134-2","article-title":"Genetic polymorphism of the antiotensin-converting enzyme (ACE) in asthmatic patients","volume":"92","author":"Tomita","year":"1998","journal-title":"Respir Med"},{"key":"R121-8-20210202","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1034\/j.1398-9995.2000.00724.x","article-title":"Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with asthma","volume":"55","author":"Lee","year":"2000","journal-title":"Allergy"},{"key":"R122-8-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/cimm.2000.1730","article-title":"MIP-1 alpha is produced but it does not control pulmonary inflammation in response to respiratory syncytial virus infection in mice","volume":"206","author":"Domachowske","year":"2000","journal-title":"Cell Immunol"},{"key":"R123-8-20210202","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.4049\/jimmunol.165.5.2677","article-title":"The chemokine macrophage-inflammatory protein-1 alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection","volume":"165","author":"Domachowske","year":"2000","journal-title":"J Immunol"},{"key":"R124-8-20210202","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/JVI.75.2.878-890.2001","article-title":"Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1 alpha in lung pathology","volume":"75","author":"Haeberle","year":"2001","journal-title":"J Virol"},{"key":"R125-8-20210202","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1086\/322788","article-title":"Macrophage inflammatory protein-1 alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis","volume":"184","author":"Garofalo","year":"2001","journal-title":"J Infect Dis"},{"key":"R126-8-20210202","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00006454-200205000-00033","article-title":"Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection","volume":"21","author":"Welliver","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R127-8-20210202","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1189\/jlb.71.6.966","article-title":"Pulmonary eosinophilia in mice devoid of interleukin-5","volume":"71","author":"Domachowske","year":"2002","journal-title":"J Leuk Biol"},{"key":"R128-8-20210202","doi-asserted-by":"crossref","first-page":"30662","DOI":"10.1074\/jbc.272.49.30662","article-title":"The human CC chemokine receptor 5 (CCR5) gene","volume":"272","author":"Mummidi","year":"1997","journal-title":"J Biol Chem"},{"key":"R129-8-20210202","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1086\/377587","article-title":"Variants of the chemokine receptor CCR5 are associated with severe bronchiolitis caused by respiratory syncytial virus","volume":"188","author":"Hull","year":"2003","journal-title":"J Infect Dis"},{"key":"R130-8-20210202","doi-asserted-by":"crossref","first-page":"978","DOI":"10.7326\/0003-4819-134-10-200105150-00012","article-title":"Host determinants in HIV infection and disease: Part 2. genetic factors and implications for antiretroviral therapeutics","volume":"134","author":"Hogan","year":"2001","journal-title":"Ann Intern Med"},{"key":"R131-8-20210202","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/thorax.58.3.222","article-title":"Association of CCR5 delta 32 with reduced risk of childhood by not adult asthma","volume":"58","author":"Srivastava","year":"2003","journal-title":"Thorax"},{"key":"R132-8-20210202","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1067\/mai.2001.116122","article-title":"The role of the C-C chemokine receptor-5 delta 32 polymorphism in asthma and in the production of regulated on activation, normal T cells expressed and secreted","volume":"108","author":"Sandford","year":"2001","journal-title":"J Allergy Clin Immunol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-200401001-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:02:42Z","timestamp":1785783762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-200401001-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":131,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.inf.0000108192.94692.d2","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}